Advertisement Biobase opens new subsidiary Nihon Biobase in Japan - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Biobase opens new subsidiary Nihon Biobase in Japan

Germany-based bioinformatics company Biobase has opened a new subsidiary, Nihon Biobase in Yokohama, Japan. The main purpose of this new subsidiary will be the enhancement of customer contact, improved cooperation with partners and the building of a new market for biomarker discovery.

The establishment of Nihon Biobase was done within a very strict time frame of only three months. The new office, located in Shin Yokohama within the new Nisso 16 building, will coordinate the activities of its distributors and establish a new brand of biomarker discovery for both the therapeutic and diagnostic markets. These activities will be launched together with Biobase’s cooperation partners in Japan, mainly Tokyo University and GNI Limited.

Edgar Wingender, president of Biobase Germany and Nihon Biobase, said: “This new technology as service is tailored for the Japanese market, and we will undertake all efforts to serve the specific needs of our Japanese customers.”